ArticleBMC cancer2025
Familial risk of pancreatic cancer and interaction with hyperglycemia, smoking, and obesity among first-degree relatives.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe influence of hyperglycemia, smoking, and obesity on the familial risk of pancreatic cancer (PC) is incompletely understood. We quantified the risk of PC in first-degree relatives (FDRs) and evaluated potential interactions between family history and these modifiable factors.
methodsUsing the Korean National Health Insurance Database, we identified 6,217,057 individuals from 1.7 million families containing at least one FDR and followed them from 2002 to 2018. Hazard ratios (HRs) for incident PC were estimated for individuals with versus without an affected FDR. Additive interaction between family history and hyperglycemia, smoking, or obesity was assessed with the relative excess risk due to interaction (RERI).
resultsIndividuals with an affected FDR had 43 newly diagnosed cases of PC, with an adjusted HR of 2.46 (95% CI, 1.81–3.33), corresponding to an incidence of 0.51 per 10,000 person-years. Risk was greatest when the affected relative was a sibling (HR 13.57; 95% CI, 6.08–30.26), followed by an affected mother (HR 2.35; 95% CI, 1.45–3.78) and father (HR 2.05; 95% CI, 1.32–3.19). Familial risk was higher in younger participants and in women. Among those with an affected FDR, hyperglycemia (HR 3.48; 95% CI, 1.12–10.82), smoking (HR 3.24; 95% CI, 2.13–4.93), and obesity (HR 2.89; 95% CI, 1.81–4.62) further increased PC risk. RERI values were close to zero, indicating little additive interaction between family history and these factors.
conclusionFDRs of patients with PC have an approximately 2.5-fold elevated risk, which is further compounded—but not synergistically amplified—by hyperglycemia, smoking, or obesity. Individuals who harbor both familial and lifestyle risk factors should be considered for genetic counseling and life style modification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.